《大行報告》花旗:太保(02601.HK)壽險新業務價值增長跑贏同業 評級「買入」
花旗發表報告,總結太保(02601.HK)業績後電話會議的重點。太保上半年壽險新業務價值增長超出同業,管理層解釋是因為在新的中介人管理政策下,中介人的業務能力提升,上半年中介人平均每月的首年保費及首年佣金,按年分別增長35%及62%,另外提升銷售模式,令產品結構傾向較長期的產品,以及提升招聘質素、優化銀行保險產品、短期儲蓄產品需求增加,亦有助推動增長。
管理層指第一期改革已按進度完成,第二期改革會聚焦於、繼續改善中介人的業務能力,增加產品組合,例如退休保障等長期產品。該行對太保持「買入」評級,目標價30元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.